| ACT | adoptive cell transfer |
| ADCC | antibody-dependent cellular cytotoxicity |
| APC | antigen-presenting cell |
| BC | breast cancer |
| CAML | cancer-associated macrophage-like cell |
| CAR | chimeric antigen receptor |
| CDC | complement-dependent cytotoxicity |
| CMC | circulating melanoma cell |
| CRC | colorectal cancer |
| CS | CellSearch |
| CSC | cancer stem cell |
| CTC | circulating tumor cell |
| CTL | cytotoxic T lymphocyte |
| CTM | circulating tumor microemboli |
| DC | dendritic cell |
| DCreg | regulatory dendritic cell |
| DFS | disease-free survival |
| ECM | extracellular matrix |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial-to-mesenchymal transition |
| EpCAM | epithelial cell adhesion molecule |
| FAS | first apoptosis signal receptor |
| FDA | Food and Drug Administration |
| G-CSF | granulocyte-colony stimulating factor |
| HER2 | human epidermal growth factor receptor 2 |
| ILC2 | type 2 innate lymphoid cell |
| mAb | monoclonal antibody |
| MAM | metastasis-associated macrophage |
| MHC | major histocompatibility complex |
| MDSC | myeloid-derived suppressor cell |
| MET | mesenchymal-to-epithelial transition |
| MTF | macrophage–tumor cell fusion |
| NET | neutrophil extracellular trap |
| NK (cell) | natural killer (cell) |
| NSCLC | non-small cell lung cancer |
| OS | overall survival |
| PBMC | peripheral blood mononuclear cell |
| PD-L1 | programmed death-ligand 1 |
| PFS | progression-free survival |
| PMo | patrolling monocyte |
| RANKL | nuclear factor kappa-B ligand |
| TAM | tumor-associated macrophage |
| tBreg | tumor-evoked regulatory B cell |
| TCR | T cell receptor |
| TDSF | tumor-derived soluble factor |
| Th (cell) | T helper (cell) |
| TIL | tumor-infiltrating lymphocyte |
| TLR | Toll-like receptor |
| Treg | regulatory T lymphocyte |
| VCAM-1 | vascular cell adhesion molecule-1 |